Blood‑Brain Barrier: Structure, Function & Clinical Significance

The blood‑brain barrier (BBB) is a highly selective semipermeable interface formed by brain microvascular endothelial cells, protecting neural tissue from blood‑borne toxins, pathogens, and fluctuations.

Cellular Components

  • Endothelial cells: Tight junctions (claudin‑5, occludin, ZO‑1) → high trans‑endothelial electrical resistance (TEER >1500 Ω·cm²).
  • Basement membrane: Collagen IV, laminin, fibronectin.
  • Astrocytic end‑feet: Enwrap >90% of capillary surface; secrete factors maintaining BBB (GDNF, TGF‑β, angiopoietin‑1).
  • Pericytes: Embedded in basement membrane; regulate capillary diameter, angiogenesis, immune cell trafficking.
  • Microglia: Survey perivascular space; respond to barrier breach.

Transport Mechanisms

  • Paracellular: Severely restricted (tight junctions).
  • Transcellular:
    • Passive diffusion: Small lipophilic molecules (O₂, CO₂, ethanol, steroid hormones).
    • Carrier‑mediated: GLUT1 (glucose), LAT1 (large neutral AAs), MCT1 (lactate/ketones).
    • Receptor‑mediated transcytosis: Transferrin, insulin, leptin receptors.
    • Active efflux: P‑gp (ABCB1), BCRP, MRPs – protect brain from xenobiotics.

Clinical Implications

  • Drug delivery: CNS drugs must cross BBB (lipophilicity, MW <400, low PSA) or use transporters.
  • Neuroinflammation: Cytokines (TNF‑α, IL‑1β) disrupt tight junctions → leukocyte infiltration (MS, encephalitis).
  • Stroke: Ischemia → BBB breakdown → vasogenic edema → hemorrhagic transformation risk.
  • Neurodegeneration: BBB dysfunction precedes amyloid deposition in Alzheimer's.

Assessment

  • Dynamic contrast‑enhanced MRI (Ktrans).
  • CSF/serum albumin ratio (Qalb).
  • Evans blue / fluorescent tracers (experimental).

Brain & Nervous System - Related Articles